Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carboplatin + paclitaxel with or without cetuximab in advanced or recurrent cervical cancer
2009-010099-74Phase 2Completed
- Sponsor
- Istituto Nazionale Tumori IRCCS Fondazione Pascale
- Start
- Apr 2009
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised trial of cetuximab in Cervical Cancer (CC) (2 arms), sponsored by Istituto Nazionale Tumori IRCCS Fondazione Pascale. Primary endpoint: Event-free survival. Started Apr 2009; status: completed.
02
Drugs
cetuximab
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on 2009-010099-74.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-010099-74.